EDAP’s Focal One Ultrasound Device Wins Russian Approval

Therapeutic ultrasound provider EDAP has scored approval in Russia for its Focal One from the country’s Federal Service for Surveillance in Healthcare.

Focal One – a  high-intensity focused ultrasound is designed for the focal therapy of prostate cancer.

Focal One  is CE marked but is not approved by the FDA. — Michael Cipriano